In another meta-analysis involving EC patients who received PD-1/PD-L1 inhibitor monotherapy (24), the most common treatment-related AE of any grade was fatigue (19.77%), followed by nausea (13.33%), diarrhea (13.10%), anemia (11.95%), and hypothyroidism (9.77%). This evidence concerns the gene CD274 and anemia.